`By: Michael T. Rosato (mrosato@wsgr.com)
`Steven W. Parmelee (sparmelee@wsgr.com)
`Sonja R. Gerrard (sgerrard@wsgr.com)
`WILSON SONSINI GOODRICH & ROSATI
`701 Fifth Avenue, Suite 5100
`Seattle, WA 98104-7036
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`_____________________________
`
`
`MODERNA THERAPEUTICS, INC.,
`Petitioner,
`
`v.
`
`PROTIVA BIOTHERAPEUTICS, INC.,
`Patent Owner.
`_____________________________
`
`Case IPR2018-00739
`Patent No. 9,364,435
`_____________________________
`
`
`PATENT OWNER PROTIVA BIOTHERAPEUTICS, INC.’S
`POWER OF ATTORNEY
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.10(b), Patent Owner Protiva Biotherapeutics, Inc.
`
`hereby appoints the practitioners associated with Wilson Sonsini Goodrich &
`
`Rosati, Customer Number 21971, including the following lead and back-up
`
`counsels, as its attorneys to transact all business in the United States Patent &
`
`Trademark Office associated with a petition for inter partes review of U.S. Patent
`
`No. 9,364,435:
`
`Lead Counsel
`Michael T. Rosato
`USPTO Reg. No. 52,182
`WILSON SONSINI GOODRICH &
`ROSATI
`701 Fifth Avenue, Suite 5100
`Seattle, WA 98104-7036
`Tel.: 206-883-2529
`Fax: 206-883-2699
`Email: mrosato@wsgr.com
`
`
`Back-Up Counsel
`Steven W. Parmelee
`USPTO Reg. No. 31,990
`WILSON SONSINI GOODRICH &
`ROSATI
`701 Fifth Avenue, Suite 5100
`Seattle, WA 98104-7036
`Tel.: 206-883-2542
`Fax: 206-883-2699
`Email: sparmelee@wsgr.com
`Sonja R. Gerrard
`USPTO Reg. No. 72,802
`WILSON SONSINI GOODRICH &
`ROSATI
`701 Fifth Avenue, Suite 5100
`Seattle, WA 98104-7036
`Tel.: 206-883-2649
`Fax: 206-883-2699
`Email: sgerrard@wsgr.com
`
`
`
`
`By: ______________________________
`For: Patent Owner Protiva Biotherapeutics, Inc.
`Name: Mark Murray
`Title: President and CEO of Arbutus Biopharma
`Corporation
`Date: ____________________________
`
`
`
`-1-
`
`March 13, 2018
`
`